Location: Home
  • search
  • go
  • Relate News
  • 1/27/2026China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
  • 1/27/2026China's Labs Pull Ahead as Global Drugmakers Invest in Biotech Pioneer...
  • 1/26/2026Huahui Wins Conditional Approval in China for First Hepatitis D Therap...
  • 1/26/2026BMS Accelerates Global Development of PD-L1/VEGF Bispecific After Biot...
  • 1/26/2026Visen's Lonapegsomatropin Approved in China for Pediatric GHD
  • 1/26/2026NMPA Suspends Import and Use of Chlorpheniramine Maleate API from Supr...
  • 1/26/2026NMPA Suspends Import, Sale and Use of Sun Pharma's Rivastigmine Capsul...
  • 1/24/2026Recent Executive Moves
  • 1/23/2026Insilicon Secures FDA IND Clearance for Oral NLRP3 Inhibitor ISM8969
  • 1/23/2026Mabwell Advances CDH17 ADC Program with First U.S. Patient Dosed
  • 1/23/2026Livzon Moves to Acquire Majority Stake in Vietnam's Imexpharm
  • 1/23/2026China's Commercial Health Insurance Payouts for Innovative Drugs and D...
  • 1/22/2026AbbVie Secures China Approval for Skyrizi in Ulcerative Colitis
  • 1/22/2026T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T
  • 1/22/2026Genmab Halts Development of Three China-Originated Oncology Assets fro...
  • 1/22/2026China Unveils New Policy to Transform Pharmacies into Community Health...
  • 1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy
  • 1/22/2026China Companion Animal Health Market to Reach US$ 3.7B by 2030
  • 1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences
  • 1/21/2026Pfizer Pulls Back on Mesothelin-Targeting ADC Sublicensed from Harbour...
  • 1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
  • 1/20/2026GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...
  • 1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...
  • 1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...
  • 1/17/2026Recent Executive Moves
  • 1/16/2026Simcere Zaiming Files for Hong Kong IPO to Accelerate Oncology Pipelin...
  • 1/16/2026Sanofi Gains Approval for Two Innovative Therapies in China
  • 1/16/2026WuXi Biologics and WuXi XDC Launch HK$1.86B Takeover Bid for BioDLink
  • 1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...
  • 1/14/2026XellSmart Completes Series C1 Financing
  • Page:1/377 Total number of articles:11308: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group